Tailored Clinical Research Solutions
We partner with sponsors to design and deliver flexible, end-to-end solutions — from early strategy and
study design to execution and regulatory navigation — ensuring controlled and predictable clinical trial delivery.
We support sponsors in developing scientifically sound clinical development strategies aligned with regulatory expectations and unmet medical needs.
Our approach integrates medical insight with operational feasibility to protect both scientific validity and investment efficiency.
Medex provides structured regulatory affairs support, including:
Regulatory authority submissions
Ethics committee applications
Round-the-clock online support
Response management
Ongoing compliance monitoring
We proactively map regulatory pathways to minimize avoidable delays and ensure predictable study initiation timelines.
Robust study design is critical for regulatory approval and market access. We provide:
Protocol development
Endpoint definition
Feasibility validation
Risk-based operational planning
Our methodology-driven approach supports data integrity and long-term regulatory acceptance.
Efficient clinical trial management requires disciplined coordination. Medex ensures:
Clear operational planning
Vendor alignment
Structured site communication
Monitoring oversight
Budget transparency
Our goal is controlled execution without compromising scientific quality.
Rare and niche programs operate under tighter constraints:
Limited patient pools
Enrollment uncertainty
High regulatory sensitivity
Investor-driven timelines
Medex CRO provides medically led, risk-aware clinical execution in Türkiye designed to reduce variability and protect development milestones.
In rare indications, overestimation can compromise entire programs.
We base feasibility on:
Direct investigator intelligence
Competing trial analysis
Patient pathway insight
Conservative enrollment forecasting
We plan for reality — not optimism.
Biotech sponsors work directly with experienced medical and operational leaders.
Rapid decision-making
Clear accountability
Transparent milestone control
No unnecessary hierarchy. No diluted responsibility.
Our physician-led model supports:
Rare disease trials
Oncology & hematology programs
Early-phase biotech studies
Medically complex protocols
Medical device investigations
We combine scientific depth with structured operational execution.
For biotech companies, clinical execution impacts regulatory progression and valuation.
We integrate risk-based planning, data oversight, and regulatory alignment to ensure defensible, regulator-ready evidence.